calendar>>May 24. 2012 Juch 101
Specific Remedy for Thrombosis Manufactured in DPRK
Pyongyang, May 24 (KCNA) -- Drawing visitors' deep interest at the recent 15th Pyongyang Spring International Trade Fair was the Jiryong capsule, a specific remedy for thrombosis, presented by the New Technology Exchange Company of the Democratic People's Republic of Korea.

This capsule is a new thrombolytic preparation. The chief ingredient is Lumbrokinase, thrombolytic enzyme, separated from earthworm that has been used as a source of Koryo medicine for thousands of years.

Kim Jong Guk, section chief of the Company, told KCNA:

This remedy has overcome the defects of previous thrombolytic preparations and is efficacious scores of times higher.

The clinical trials, conducted at several leading hospitals in recent five years, showed that its efficiency was more than 94 percent.

Ingredients of the remedy are earthworm (thrombolytic activity 12,000 IU/cap), sodium alginate, mint plant and etc.

After absorption by digestion organs into blood vessel, the capsule is absorbed into blood clot and dissolves it directly as plasmin does.

It also has such functions as anti-platelet, anti-coagulation and anti-oxidation, so it is very ideal for preventing and curing thrombosis.

The capsule treats and prevents all of thrombus-related diseases, such as cerebral thrombosis, myocardial infarction, anginose, hepatofibrosis, nephrocirrhosis and spontaneous gangrene and their prodromal symptoms and arteriosclerosis.

In case of diabetes by pancreatic infarction, its administration is the most active cause treatment.

The Jiryong capsule is now popular on Asian and European markets.

Copyright (C) KOREA NEWS SERVICE(KNS) All Rights Reserved.